체중 가벼운
청소년, 여성에서 몰쌀.
'모더나'
백신 식염수 섞지 않음.
그러나 100mcg 이라는 쥐 치사량 25배 샷.
이것을 3차까지 한다면 ㄷㄷㄷ 75배
4차까지면 100배.
쥐 새끼 몸무게, 사람 체중 = 비교시 사망 !
화이자
3,4차까지 간다면
백신 식염수의 산화그래핀은 느끈
쥐 치사량 100배 도달 장담 가능
원액, 백신식염수 분리 접근 해야 할수도.
ㅇㅇ(77.111) 2022.01.11 14:34:44
'화이자'
병(vial)은 5인분.
천천히 상하 뒤집기 10회로 흔들어 분말가루(30mcg) 흐트리고
주사기로 백신 식염수(1.8mL)를 넣고 다시 상하 천천히 흔들어 균일 섞고
다시 주사기를 5회 꽂고 매회 1인분(6mcg, 0.36mL) 샷
'모더나'
1인용 병(100mcg,0.5mL) 샷
모더나 코로나 백신은 100mg 2회 접종한다고 하고 100 mcg of mRNA-1273 administered through 0.5 mL intramuscular injection in the deltoid muscle on Days 1 and 29 in participants from 18-55 years of age. N=15 (4 sentinel, 11 non-sentinel). 화이자 mRNA Vaccine BNT162b2. This is a multidose vial and must be diluted before use. 1 vial (0.45 mL) contains 5 doses of 30 micrograms of BNT162b2 RNA (embedded in lipid nanoparticles). = 6mcg (0.36mL) ㅋ
COVID-19 mRNA Vaccine BNT162b2 is highly purified single-stranded, 5’-capped messenger RNA (mRNA) produced by cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2. 6.1 List of excipients ALC-0315 = (4-hydroxybutyl) azanediyl)bis (hexane-6,1-diyl)bis(2-hexyldecanoate) ALC-0159 = 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide 1,2-Distearoyl-sn-glycero-3-phosphocholine cholesterol potassium chloride potassium dihydrogen phosphate sodium chloride disodium hydrogen phosphate dihydrate sucrose water for injections The thawed vaccine must be diluted in its original vial with 1.8 mL sodium chloride 9 mg/mL (0.9%) solution for injection, using a 21 gauge or narrower needle and aseptic techniques. |
여기서 부터는 산화 그래핀의 쥐 실험 치사량 :::
(전략) but graphene oxide specifically showed no obvious toxicity at low doses or middle doses from .1 to .25 mg.
It was chronically toxic at higher doses of .4 mg, where it was found to deposit in the lungs, liver, spleen, and kidneys.
It is important to note that this .4 mg of graphene oxide is proportionally much greater in mice than it would be in humans, considering their size and biological differences. (후략)
댓글 0